NEW YORK (GenomeWeb) – MBio Diagnostics, a developer of point-of-care diagnostic and sample testing technologies, announced on Thursday that it has closed a $6.3 million Series B round of financing.

The company said that the proceeds of the round will be used to refine its multiplex analyzer platform, which is based on proprietary planar waveguide and fluorescent detection technology, and make improvements to its manufacturing. The Boulder, Colorado-based firm said the system can detect a variety of analytes including proteins, cells, nucleic acids, and small molecules.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.